Screening for esophageal adenocarcinoma: An evidence-based approach

American Journal of Medicine

Volumn 113, Issue 6, 2002, Pages 499-505

  Gerson, Lauren B ^a,c   Triadafilopoulos, George ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENDOSCOPY; ESOPHAGUS CARCINOMA; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METHODOLOGY; OBESITY; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SYMPTOM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CYTODIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; EVIDENCE-BASED MEDICINE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MASS SCREENING; OCCULT BLOOD; QUESTIONNAIRES; RISK FACTORS;

EID: 0037109553     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01234-2     Document Type: Article

References (80)

1. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER Cancer Statistics Review, 1973-1978. 2001;National Cancer Institute, Bethesda, Maryland.
2. Rogers E.L., Goldkind S.F., Iseri O.A., et al. Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett's esophagus. J Clin Gastroenterol. 8:1996;613-618.
3. Heitmiller R.F., Sharma R.R. Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg. 112:1996;130-136.
4. Botterweck A.A., Schouten L.J., Volovics A., et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 29:2000;645-654.
5. Bytzer P., Christensen P.B., Damkier P., et al. Adenocarcinoma of the esophagus and Barrett's esophagus a population-based study . Am J Gastroenterol. 94:1999;86-91.
6. Blot W.J., Devesa S.S., Kneller R.W., Fraumeni J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287-1289.
7. Braghetto I., Csendes A., Cornejo A., et al. Survival of patients with esophageal cancer subjected to total thoracic esophagectomy. Rev Med Chil. 128:2000;64-74.
8. Karl R.C., Schreiber R., Boulware D., et al. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg. 231:2000;635-643.
9. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 339:1998;1979-1984.
10. Salazar J.D., Doty J.R., Lin J.W., et al. Does cell type influence post-esophagectomy survival in patients with esophageal cancer? Dis Esophagus. 11:1998;168-171.
11. Streitz J.M. Jr, Andrews C.W. Jr, Ellis F.H. Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg. 105:1993;383-387.
12. Zhang Z.F., Kurtz R.C., Sun M., et al. Adenocarcinomas of the esophagus and gastric cardia medical conditions, tobacco, alcohol, and socioeconomic factors . Cancer Epidemiol Biomarkers Prev. 5:1996;761-768.
13. Vaughan T.L., Davis S., Kristal A., Thomas D.B. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia adenocarcinoma versus squamous cell carcinoma . Cancer Epidemiol Biomarkers Prev. 4:1995;85-92.
14. Lagergren J., Bergstrom R., Lindgren A., Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 340:1999;825-831.
15. Dulai G.S., Guha S., Kahn K.L., et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma a systematic review . Gastroenterology. 122:2002;26-33.
16. Dent J., Brun J., Fendrick A.M., et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut. 44:(suppl):1999;S1-S16.
17. Buttar N.S., Wang K.K., Sebo T.J., et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology. 120:2001;1630-1639.
18. Reid B.J., Prevo L.J., Galipeau P.C., et al. Predictors of progression in Barrett's esophagus II baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression . Am J Gastroenterol. 96:2001;2839-2848.
19. Montgomery E., Goldblum J.R., Greenson J.K., et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus a follow-up study based on 138 cases from a diagnostic variability study . Hum Pathol. 32:2001;379-388.
20. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 120:2001;1607-1619.
21. Van Sandick J.W., Van Lanschot J.J., Kuiken B.W., et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 43:1998;216-222.
22. Sabel M.S., Pastore K., Toon H., Smith J.L. Adenocarcinoma of the esophagus with and without Barrett's mucosa. Arch Surg. 135:2000;831-835.
23. Lerut T., Coosemans W., Van Raemdonck D., et al. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg. 107:1994;1059-1065.
24. Fitzgerald R.C., Saeed I.T., Khoo D., et al. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci. 46:2001;1892-1898.
25. Galandiuk S., Hermann R.E., Cosgrove D.M., Gassman J.J. Cancer of the esophagus. The Cleveland Clinic experience. Ann Surg. 23:1986;101-108.
26. Corley D.A., Levin T.R., Habel L.A., et al. Surveillance and survival in Barrett's adenocarcinomas a population-based study . Gastroenterology. 122:2002;633-640.
27. Lagergren J., Bergstrom R., Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 130:1999;883-890.
28. Terry P., Lagergren J., Hansen H., et al. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev. 10:2001;365-369.
29. Lagergren J., Bergstrom R., Lindgren A., Nyren O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer. 85:2000;340-346.
30. Gerson L.B., Lavori P.W., Edson B., Triadafilopoulos G. Use of a symptom questionnaire to predict barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol. 96:2001;2005-2012.
31. Eloubeidi M.A., Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease a multivariable analysis in veterans . J Clin Gastroenterol. 33:2001;306-309.
32. Conio M., Filiberti R., Blanchi S., et al. Risk factors for Barrett's esophagus a case-control study . Int J Cancer. 97:2002;225-229.
33. Zaman A., Hahn M., Hapke R., et al. A randomized trial of peroral versus transnasal unsedated endoscopy using an ultrathin videoendoscope. Gastrointest Endosc. 49:1999;279-284.
34. Dumortier J., Ponchon T., Scoazec J.Y., et al. Prospective evaluation of transnasal esophagogastroduodenoscopy feasibility and study on performance and tolerance . Gastrointest Endosc. 49:1999;285-291.
35. Craig A., Hanlon J., Dent J., Schoeman M. A comparison of transnasal and transoral endoscopy with small-diameter endoscopes in unsedated patients. Gastrointest Endosc. 49:1999;292-296.
36. Gerson L.B., Shetler K., Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic adults. Gastroenterology. 123:2002;461-467.
37. Chen Y.M., Gelfand D.W., Ott D.J., Wu W.C. Barrett esophagus as an extension of severe esophagitis analysis of radiologic signs in 29 cases . Am J Roentgenol. 145:1985;275-281.
38. Yamamoto A.J., Levine M.S., Katzka D.A., et al. Short-segment Barrett's esophagus findings on double-contrast esophagography in 20 patients . Am J Roentgenol. 176:2001;1173-1178.
39. Bini E.J., Rajapaksa R.C., Valdes M.T., Weinshel E.H. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy? Am J Med. 106:1999;613-618.
40. Hsia P.C., al-Kawas F.H. Yield of upper endoscopy in the evaluation of asymptomatic patients with hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol. 87:1992;1571-1574.
41. Nakama H., Kamijo N., Fattah A.S., Zhang B. Immunologic detection of fecal occult blood from upper digestive tract diseases. Hepatogastroenterology. 45:1998;752-754.
42. MacLennan A.J., Orringer M.B., Beer D.G. Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology. Mol Carcinog. 24:1999;137-143.
43. Hardwick R.H., Morgan R.J., Warren B.F., et al. Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. Dis Esophagus. 10:1997;233-237.
44. Alexander J.A., Jones S.M., Smith C.J., et al. Usefulness of cytopathology and histology in the evaluation of Barrett's esophagus in a community hospital. Gastrointest Endosc. 46:1997;318-320.
45. Wang H.H., Sovie S., Zeroogian J.M., et al. Value of cytology in detecting intestinal metaplasia and associated dysplasia at the gastroesophageal junction. Hum Pathol. 28:1997;465-471.
46. Geisinger K.R., Teot L.A., Richter J.E. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer. 69:1992;8-16.
47. Falk G.W., Chittajallu R., Goldblum J.R., et al. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology. 112:1997;1787-1797.
48. Fahmy N., King J.F. Barrett's esophagus an acquired condition with genetic predisposition . Am J Gastroenterol. 88:1993;1262-1265.
49. Eng C., Spechler S.J., Ruben R., Li F.P. Familial Barrett's esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 2:1993;397-399.
50. Poynton A.R., Walsh T.N., O'Sullivan G., Hennessy T.P. Carcinoma arising in familial Barrett's esophagus. Am J Gastroenterol. 91:1996;1855-1856.
51. Romero Y., Cameron A.J., Locke G.R.I.I.I., et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 113:1997;1449-1456.
52. Trudgill N.J., Kapur K.C., Riley S.A. Familial clustering of reflux symptoms. Am J Gastroenterol. 94:1999;1172-1178.
53. Zaman A., Hapke R., Sahagun G., Katon R.M. Unsedated peroral endoscopy with a video ultrathin endoscope patient acceptance, tolerance, and diagnostic accuracy . Am J Gastroenterol. 93:1998;1260-1263.
54. Padda S., Ramirez F. Accuracy in the diagnosis of short-segment Barrett's esophagus the role of endoscopic experience . Gastrointest Endosc. 54:2001;605-608.
55. Drewitz D.J., Sampliner R.E., Grewal H.S. The incidence of adenocarcinoma in Barrett's esophagus a prospective study of 170 patients followed 4.8 years . Am J Gastroenterol. 92:1997;212-215.
56. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 120:2001;1607-1619.
57. Eckardt V.F., Kanzler G., Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus a prospective controlled investigation . Am J Med. 111:2001;33-37.
58. Zaninotto G., Parenti A.R., Ruol A., et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg. 87:2000;1102-1105.
59. Saubier E.C., Gouillat C., Samaniego C., et al. Adenocarcinoma in columnar-lined Barrett's esophagus. Analysis of 13 esophagectomies. Am J Surg. 150:1985;365-369.
60. Edwards M.J., Gable D.R., Lentsch A.B., Richardson J.D. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg. 223:1996;585-589.
61. Ahmad N.A., Kockman M.L., Long W.B., et al. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection a study of 101 cases . Gastrointest Endosc. 55:2002;390-396.
62. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 118:2000;670-677.
63. Overholt B.F., Panjehpour M., Haydek J.M. Photodynamic therapy for Barrett's esophagus follow-up in 100 patients . Gastrointest Endosc. 49:1999;1-7.
64. Gossner L., May A., Stolte M., et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc. 49:1999;8-12.
65. Sharma P., Jaffe P.E., Bhattacharyya A., Sampliner R.E. Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma long-term follow-up . Gastrointest Endosc. 49:1999;442-446.
66. Van Laethem J.L., Jagodzinski R., Peny M.O., et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy. 33:2001;257-261.
67. Montes C.G., Brandalise N.A., Deliza R., et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc. 50:1999;173-177.
68. Sharma P., Bhattacharyya A., Garewal H.S., Sampliner R.E. Durability of a new squamous epithyelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc. 50:1999;159-164.
69. Kovacs B.J., Chen Y.K., Lewis T.D., et al. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc. 49:1999;547-553.
70. Van Laethem J.L., Cremer M., Peny M.O., et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression immediate and mid term results . Gut. 43:1998;747-751.
71. Pereira-Lima J.C., Busnello J.V., Saul C., et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol. 95:2000;1661-1668.
72. Schulz H., Miehlke S., Antos D., et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc. 51:2000;659-663.
73. Tigges H., Fuchs K.H., Maroske J., et al. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J Gastrointest Surg. 5:2001;251-259.
74. Haynes R.B., Sackett D.L., Taylor D.W., et al. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. 299:1978;741-744.
75. Johnston M.E., Gibson E.S., Terry C.W., et al. Effects of labelling on income, work and social function among hypertensive employees. J Chronic Dis. 37:1984;417-423.
76. Feig D.S., Chen E., Naylor C.D. Self-perceived health status of women three to five years after the diagnosis of gestational diabetes a survey of cases and matched controls . Am J Obstet Gynecol. 178:1998;386-393.
77. Silvis S.E., Nebel O., Rogers G., et al. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA. 235:1976;928-930.
78. Clarke G.A., Jacobson B.C., Hammett R.J., Carr-Locke D.L. The indications, utilization and safety of gastrointestinal endoscopy in an extremely elderly patient cohort. Endoscopy. 33:2001;580-584.
79. Sieg A., Hachmoeller-Eisenbach U., Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy a survey among German gastroenterologists . Gastrointest Endosc. 53:2001;620-627.
80. Schauer P.R., Schwesinger W.H., Page C.P., et al. Complications of surgical endoscopy. A decade of experience from a surgical residency training program. Surg Endosc. 11:1997;8-11.